elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Sclera
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Sclera
RIS
0.000
(Research Intensity Score)
Papers
84
Top papers
Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma
2024 · 69 citations
Intraocular pressure is a promising target for myopia control
2025 · 10 citations
Central Corneal Thickness and Glaucoma Risk: The Importance of Corneal Pachymetry in Screening Adults Over 50 and Glaucoma Suspects
2025 · 8 citations
Finite Element Analysis of Ocular Impact Forces and Potential Complications in Pickleball-Related Eye Injuries
2025 · 6 citations
Investigation of magnetically driven passage of magnetic nanoparticles through eye tissues for magnetic drug targeting
2020 · 22 citations
Newest papers
Potential of Fenofibric Acid as Topical Eye Drops for Management of Dry Eye Syndrome
2026 · 1 citations
Neurological Symptoms Associated with Longstanding Orbital Foreign Body
2026
Case Report: A research on a case of hereditary spherocytosis with idiopathic pulmonary hemosiderosis
2026
Intraocular pressure is a promising target for myopia control
2025 · 10 citations
Central Corneal Thickness and Glaucoma Risk: The Importance of Corneal Pachymetry in Screening Adults Over 50 and Glaucoma Suspects
2025 · 8 citations
A sample from the 84 top papers behind Sclera.
Create a free account to browse them all →
Sclera's history
Research intensity over time
Explore Sclera's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Sclera's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link